Yongin-si, South Korea

M Ramamohan


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: M Ramamohan: Innovator in Pharmaceutical Chemistry

Introduction

M Ramamohan is a distinguished inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing complex compounds. His innovative approach has led to advancements in the preparation of high-purity pharmaceuticals.

Latest Patents

M Ramamohan holds a patent for a method titled "Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide." This patent describes a method capable of preparing N-[4-[(1R)-1-[[(R)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-2,6-difluorophenyl]-methanesulfonamide (INT028-2) with high optical purity. The method utilizes Ellman-chiral auxiliaries and involves recrystallization and separation of optical isomers. This innovative process allows for the production of high-purity compounds at room temperature, significantly reducing the failure rate associated with cryogenic processes.

Career Highlights

M Ramamohan is currently employed at Amorepacific Corporation, where he continues to apply his expertise in pharmaceutical development. His work has been instrumental in enhancing the quality and efficiency of drug manufacturing processes. With a focus on optical purity, his contributions are vital to the pharmaceutical industry.

Collaborations

M Ramamohan has collaborated with notable colleagues, including Byoung Young Woo and Ki-Wha Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

M Ramamohan's contributions to pharmaceutical chemistry exemplify the impact of innovative methods in drug development. His patent for a high-purity synthesis method showcases his commitment to advancing the field. Through his work at Amorepacific Corporation and collaborations with esteemed colleagues, he continues to drive progress in pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…